Cargando…
The safety and efficacy of laparoscopic gastrectomy for patients with locally advanced gastric cancer following neoadjuvant chemotherapy
Limited researches focused on the application of laparoscopic gastrectomy (LG) in locally advanced gastric cancer (LAGC) patients following neoadjuvant chemotherapy (NACT). In this study, we aimed at illustrating the surgical and survival outcome of LG in LAGC patients following NACT. We performed a...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209419/ https://www.ncbi.nlm.nih.gov/pubmed/35726012 http://dx.doi.org/10.1038/s41598-022-14717-6 |
_version_ | 1784729951296028672 |
---|---|
author | Liu, Lihang Wang, Chuandong Li, Feng Zhang, Xiaojuan Cheng, Xuefei Lin, Shengtao Liu, Yi Yang, Changshun Li, Weihua |
author_facet | Liu, Lihang Wang, Chuandong Li, Feng Zhang, Xiaojuan Cheng, Xuefei Lin, Shengtao Liu, Yi Yang, Changshun Li, Weihua |
author_sort | Liu, Lihang |
collection | PubMed |
description | Limited researches focused on the application of laparoscopic gastrectomy (LG) in locally advanced gastric cancer (LAGC) patients following neoadjuvant chemotherapy (NACT). In this study, we aimed at illustrating the surgical and survival outcome of LG in LAGC patients following NACT. We performed a retrospective study of patients with LAGC who received either LG following NACT or upfront LG at Fujian Provincial Hospital between March 2013 and October 2018. Perioperative parameters, short-term and long-term outcomes were compared. The Kaplan–Meier estimator was used to describe the survival curves, and the differences were examined by the log-rank test. In total, 76 consecutive patients were enrolled into the NACT-LG (41 patients) and LG (35 patients) group. The postoperative hospital stay was significantly longer for LG than for NACT-LG (11.0 vs. 12.0 day, P = 0.031). Significant difference was found in Grade ≥ III severe postoperative complications in two groups (0 vs. 17.1%, P = 0.001). No patient died of postoperative complications in the NACT-LG group, and one patient (1/35, 2.9%) died of postoperative complications in the LG group. A forest plot revealed that most subgroups of LG group were at great risks of postoperative complications. Compared with the LG group, the NACT-LG group had a significantly better DFS (14.4% vs. 5.7%, P = 0.0299) and better OS (34.1% vs. 8.6%, P = 0.0061) at 3 years. NACT increased the safety of LG for patients with LAGC and offer better disease-free and overall survival. For patients with LAGC, LG following NACT should be the priority treatment. |
format | Online Article Text |
id | pubmed-9209419 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-92094192022-06-22 The safety and efficacy of laparoscopic gastrectomy for patients with locally advanced gastric cancer following neoadjuvant chemotherapy Liu, Lihang Wang, Chuandong Li, Feng Zhang, Xiaojuan Cheng, Xuefei Lin, Shengtao Liu, Yi Yang, Changshun Li, Weihua Sci Rep Article Limited researches focused on the application of laparoscopic gastrectomy (LG) in locally advanced gastric cancer (LAGC) patients following neoadjuvant chemotherapy (NACT). In this study, we aimed at illustrating the surgical and survival outcome of LG in LAGC patients following NACT. We performed a retrospective study of patients with LAGC who received either LG following NACT or upfront LG at Fujian Provincial Hospital between March 2013 and October 2018. Perioperative parameters, short-term and long-term outcomes were compared. The Kaplan–Meier estimator was used to describe the survival curves, and the differences were examined by the log-rank test. In total, 76 consecutive patients were enrolled into the NACT-LG (41 patients) and LG (35 patients) group. The postoperative hospital stay was significantly longer for LG than for NACT-LG (11.0 vs. 12.0 day, P = 0.031). Significant difference was found in Grade ≥ III severe postoperative complications in two groups (0 vs. 17.1%, P = 0.001). No patient died of postoperative complications in the NACT-LG group, and one patient (1/35, 2.9%) died of postoperative complications in the LG group. A forest plot revealed that most subgroups of LG group were at great risks of postoperative complications. Compared with the LG group, the NACT-LG group had a significantly better DFS (14.4% vs. 5.7%, P = 0.0299) and better OS (34.1% vs. 8.6%, P = 0.0061) at 3 years. NACT increased the safety of LG for patients with LAGC and offer better disease-free and overall survival. For patients with LAGC, LG following NACT should be the priority treatment. Nature Publishing Group UK 2022-06-20 /pmc/articles/PMC9209419/ /pubmed/35726012 http://dx.doi.org/10.1038/s41598-022-14717-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Liu, Lihang Wang, Chuandong Li, Feng Zhang, Xiaojuan Cheng, Xuefei Lin, Shengtao Liu, Yi Yang, Changshun Li, Weihua The safety and efficacy of laparoscopic gastrectomy for patients with locally advanced gastric cancer following neoadjuvant chemotherapy |
title | The safety and efficacy of laparoscopic gastrectomy for patients with locally advanced gastric cancer following neoadjuvant chemotherapy |
title_full | The safety and efficacy of laparoscopic gastrectomy for patients with locally advanced gastric cancer following neoadjuvant chemotherapy |
title_fullStr | The safety and efficacy of laparoscopic gastrectomy for patients with locally advanced gastric cancer following neoadjuvant chemotherapy |
title_full_unstemmed | The safety and efficacy of laparoscopic gastrectomy for patients with locally advanced gastric cancer following neoadjuvant chemotherapy |
title_short | The safety and efficacy of laparoscopic gastrectomy for patients with locally advanced gastric cancer following neoadjuvant chemotherapy |
title_sort | safety and efficacy of laparoscopic gastrectomy for patients with locally advanced gastric cancer following neoadjuvant chemotherapy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209419/ https://www.ncbi.nlm.nih.gov/pubmed/35726012 http://dx.doi.org/10.1038/s41598-022-14717-6 |
work_keys_str_mv | AT liulihang thesafetyandefficacyoflaparoscopicgastrectomyforpatientswithlocallyadvancedgastriccancerfollowingneoadjuvantchemotherapy AT wangchuandong thesafetyandefficacyoflaparoscopicgastrectomyforpatientswithlocallyadvancedgastriccancerfollowingneoadjuvantchemotherapy AT lifeng thesafetyandefficacyoflaparoscopicgastrectomyforpatientswithlocallyadvancedgastriccancerfollowingneoadjuvantchemotherapy AT zhangxiaojuan thesafetyandefficacyoflaparoscopicgastrectomyforpatientswithlocallyadvancedgastriccancerfollowingneoadjuvantchemotherapy AT chengxuefei thesafetyandefficacyoflaparoscopicgastrectomyforpatientswithlocallyadvancedgastriccancerfollowingneoadjuvantchemotherapy AT linshengtao thesafetyandefficacyoflaparoscopicgastrectomyforpatientswithlocallyadvancedgastriccancerfollowingneoadjuvantchemotherapy AT liuyi thesafetyandefficacyoflaparoscopicgastrectomyforpatientswithlocallyadvancedgastriccancerfollowingneoadjuvantchemotherapy AT yangchangshun thesafetyandefficacyoflaparoscopicgastrectomyforpatientswithlocallyadvancedgastriccancerfollowingneoadjuvantchemotherapy AT liweihua thesafetyandefficacyoflaparoscopicgastrectomyforpatientswithlocallyadvancedgastriccancerfollowingneoadjuvantchemotherapy AT liulihang safetyandefficacyoflaparoscopicgastrectomyforpatientswithlocallyadvancedgastriccancerfollowingneoadjuvantchemotherapy AT wangchuandong safetyandefficacyoflaparoscopicgastrectomyforpatientswithlocallyadvancedgastriccancerfollowingneoadjuvantchemotherapy AT lifeng safetyandefficacyoflaparoscopicgastrectomyforpatientswithlocallyadvancedgastriccancerfollowingneoadjuvantchemotherapy AT zhangxiaojuan safetyandefficacyoflaparoscopicgastrectomyforpatientswithlocallyadvancedgastriccancerfollowingneoadjuvantchemotherapy AT chengxuefei safetyandefficacyoflaparoscopicgastrectomyforpatientswithlocallyadvancedgastriccancerfollowingneoadjuvantchemotherapy AT linshengtao safetyandefficacyoflaparoscopicgastrectomyforpatientswithlocallyadvancedgastriccancerfollowingneoadjuvantchemotherapy AT liuyi safetyandefficacyoflaparoscopicgastrectomyforpatientswithlocallyadvancedgastriccancerfollowingneoadjuvantchemotherapy AT yangchangshun safetyandefficacyoflaparoscopicgastrectomyforpatientswithlocallyadvancedgastriccancerfollowingneoadjuvantchemotherapy AT liweihua safetyandefficacyoflaparoscopicgastrectomyforpatientswithlocallyadvancedgastriccancerfollowingneoadjuvantchemotherapy |